Random comparison of repeated faecal immunochemical testing at different intervals for population-based colorectal cancer screening.

PubWeight™: 1.14‹?› | Rank: Top 10%

🔗 View Article (PMID 22387523)

Published in Gut on March 02, 2012

Authors

Aafke H C van Roon1, S Luuk Goede, Marjolein van Ballegooijen, Anneke J van Vuuren, Caspar W N Looman, Katharina Biermann, Jacqueline C I Y Reijerink, Hans 't Mannetje, Alexandra C M van der Togt, J Dik F Habbema, Monique E van Leerdam, Ernst J Kuipers

Author Affiliations

1: Erasmus University Medical Centre, Department of Gastroenterology and Hepatology, 's Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. a.vanroon@erasmusmc.nl

Articles citing this

Colorectal cancer screening uptake over three biennial invitation rounds in the English bowel cancer screening programme. Gut (2014) 1.69

Colorectal cancer screening--optimizing current strategies and new directions. Nat Rev Clin Oncol (2013) 1.35

Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver (2014) 1.19

Colorectal cancer. Nat Rev Dis Prim (2015) 1.07

Race/Ethnicity and Adoption of a Population Health Management Approach to Colorectal Cancer Screening in a Community-Based Healthcare System. J Gen Intern Med (2016) 1.00

Advances in Fecal Occult Blood Tests: the FIT revolution. Dig Dis Sci (2014) 0.95

Cost-effectiveness of patient navigation to increase adherence with screening colonoscopy among minority individuals. Cancer (2014) 0.89

Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol (2016) 0.85

Second-Look Colonoscopies and the Impact on Capacity in FIT-Based Colorectal Cancer Screening. Am J Gastroenterol (2015) 0.83

Using the Cancer Risk Management Model to evaluate colorectal cancer screening options for Canada. Curr Oncol (2015) 0.83

Quality of life in participants of a CRC screening program. Br J Cancer (2012) 0.81

Cost-effectiveness of colorectal cancer screening in Germany: current endoscopic and fecal testing strategies versus plasma methylated Septin 9 DNA. Endosc Int Open (2014) 0.80

Developments in Screening Tests and Strategies for Colorectal Cancer. Biomed Res Int (2015) 0.80

Impact of faecal haemoglobin concentration on colorectal cancer mortality and all-cause death. BMJ Open (2013) 0.80

Fecal-based colorectal cancer screening among the uninsured in northern Manhattan. Am J Prev Med (2014) 0.80

A Blood Test for Methylated BCAT1 and IKZF1 vs. a Fecal Immunochemical Test for Detection of Colorectal Neoplasia. Clin Transl Gastroenterol (2016) 0.78

Optimal colorectal cancer screening in states' low-income, uninsured populations—the case of South Carolina. Health Serv Res (2014) 0.78

The potential of imaging techniques as a screening tool for colorectal cancer: a cost-effectiveness analysis. Br J Radiol (2016) 0.77

Colorectal Cancer Screening in Average Risk Populations: Evidence Summary. Can J Gastroenterol Hepatol (2016) 0.75

Colorectal cancer screening: Opportunities to improve uptake, outcomes, and disparities. World J Gastrointest Endosc (2016) 0.75

FITting ADR to colonoscopy indication. United European Gastroenterol J (2016) 0.75

Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening? Ann Lab Med (2018) 0.75

Articles by these authors

Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med (2005) 16.70

Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med (2012) 16.55

Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer (2010) 13.27

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report. Gut (2012) 12.62

Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet (2015) 7.99

Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev (2006) 7.72

Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2008) 6.99

Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop (2003) 6.64

International consensus recommendations on the management of patients with nonvariceal upper gastrointestinal bleeding. Ann Intern Med (2010) 6.36

Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition. Lancet (2015) 6.13

Participation and yield of colonoscopy versus non-cathartic CT colonography in population-based screening for colorectal cancer: a randomised controlled trial. Lancet Oncol (2011) 5.72

Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study. BMJ (2008) 4.77

Predicting outcome after traumatic brain injury: development and international validation of prognostic scores based on admission characteristics. PLoS Med (2008) 4.60

Women older than 40 years of age and those with elevated follicle-stimulating hormone levels differ in poor response rate and embryo quality in in vitro fertilization. Fertil Steril (2003) 4.58

New oral anticoagulants increase risk for gastrointestinal bleeding: a systematic review and meta-analysis. Gastroenterology (2013) 4.58

Initiation of population-based mammography screening in Dutch municipalities and effect on breast-cancer mortality: a systematic review. Lancet (2003) 4.20

Intravenous esomeprazole for prevention of recurrent peptic ulcer bleeding: a randomized trial. Ann Intern Med (2009) 4.11

Risk of esophageal adenocarcinoma and mortality in patients with Barrett's esophagus: a systematic review and meta-analysis. Clin Gastroenterol Hepatol (2009) 3.66

The Rotterdam Study: 2010 objectives and design update. Eur J Epidemiol (2009) 3.44

The Rotterdam Study: 2012 objectives and design update. Eur J Epidemiol (2011) 3.26

Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology (2008) 3.18

Competence measurement during colonoscopy training: the use of self-assessment of performance measures. Am J Gastroenterol (2012) 3.17

Identification of genetic loci associated with Helicobacter pylori serologic status. JAMA (2013) 3.15

Canadian Association of Gastroenterology consensus guidelines on safety and quality indicators in endoscopy. Can J Gastroenterol (2012) 3.15

Anti-Müllerian hormone levels in the spontaneous menstrual cycle do not show substantial fluctuation. J Clin Endocrinol Metab (2006) 3.13

Regulatory T cells contribute to the impaired immune response in patients with chronic hepatitis B virus infection. Hepatology (2005) 3.10

Cost-effectiveness analysis of a quantitative immunochemical test for colorectal cancer screening. Gastroenterology (2011) 3.08

High follicle-stimulating hormone levels should not necessarily lead to the exclusion of subfertile patients from treatment. Fertil Steril (2004) 3.08

Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population. J Natl Cancer Inst (2010) 3.05

Validation and updating of predictive logistic regression models: a study on sample size and shrinkage. Stat Med (2004) 2.95

Serum antimullerian hormone levels best reflect the reproductive decline with age in normal women with proven fertility: a longitudinal study. Fertil Steril (2005) 2.90

POBASCAM, a population-based randomized controlled trial for implementation of high-risk HPV testing in cervical screening: design, methods and baseline data of 44,102 women. Int J Cancer (2004) 2.89

Risk-based selection from the general population in a screening trial: selection criteria, recruitment and power for the Dutch-Belgian randomised lung cancer multi-slice CT screening trial (NELSON). Int J Cancer (2007) 2.85

Feasibility and yield of a new EUS histology needle: results from a multicenter, pooled, cohort study. Gastrointest Endosc (2011) 2.82

Residual esophageal cancer after neoadjuvant chemoradiotherapy frequently involves the mucosa and submucosa. Ann Surg (2013) 2.79

Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol (2004) 2.77

Anti-müllerian hormone is a promising predictor for the occurrence of the menopausal transition. Menopause (2004) 2.69

How much can current interventions reduce colorectal cancer mortality in the U.S.? Mortality projections for scenarios of risk-factor modification, screening, and treatment. Cancer (2006) 2.68

Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS (2008) 2.54

Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients. J Neurosurg (2003) 2.51

Substantial effective sample sizes were required for external validation studies of predictive logistic regression models. J Clin Epidemiol (2005) 2.42

Contribution of screening and survival differences to racial disparities in colorectal cancer rates. Cancer Epidemiol Biomarkers Prev (2012) 2.39

Democratization and life expectancy in Europe, 1960-2008. Soc Sci Med (2013) 2.38

Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands. J Natl Cancer Inst (2009) 2.35

Should colorectal cancer screening be considered in elderly persons without previous screening? A cost-effectiveness analysis. Ann Intern Med (2014) 2.31

Validity of prognostic models: when is a model clinically useful? Semin Urol Oncol (2002) 2.29

Stent versus gastrojejunostomy for the palliation of gastric outlet obstruction: a systematic review. BMC Gastroenterol (2007) 2.26

Double balloon enteroscopy and capsule endoscopy for obscure gastrointestinal bleeding: an updated meta-analysis. J Gastroenterol Hepatol (2011) 2.24

The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study. PLoS One (2008) 2.23

Chronic gastrointestinal ischaemia: shifting paradigms. Gut (2010) 2.23

Models in the development of clinical practice guidelines. Ann Intern Med (2014) 2.18

Human memory B cells originate from three distinct germinal center-dependent and -independent maturation pathways. Blood (2011) 2.15

Environmental factors contributing to the spread of H5N1 avian influenza in mainland China. PLoS One (2008) 2.14

Regional differences in patient characteristics, case management, and outcomes in traumatic brain injury: experience from the tirilazad trials. J Neurosurg (2002) 2.12

The shape of the relationship between income and self-assessed health: an international study. Int J Epidemiol (2004) 2.11

Colorectal neoplasia in veterans is associated with Barrett's esophagus but not with proton-pump inhibitor or aspirin/NSAID use. Gastrointest Endosc (2006) 2.10

Quality evaluation of colonoscopy reporting and colonoscopy performance in daily clinical practice. Gastrointest Endosc (2011) 2.09

High cancer risk and increased mortality in patients with Peutz-Jeghers syndrome. Gut (2011) 2.06

Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: multicentre randomised trial. Lancet (2004) 2.06

Self-assessed health and mortality: could psychosocial factors explain the association? Int J Epidemiol (2002) 2.06

Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ (2012) 2.05

A case series of proton pump inhibitor-induced hypomagnesemia. Am J Kidney Dis (2010) 1.99

Majority of patients with inflammatory bowel disease in clinical remission have mucosal inflammation. Inflamm Bowel Dis (2011) 1.97

Surgical gastrojejunostomy or endoscopic stent placement for the palliation of malignant gastric outlet obstruction (SUSTENT study): a multicenter randomized trial. Gastrointest Endosc (2009) 1.97

Individualizing colonoscopy screening by sex and race. Gastrointest Endosc (2009) 1.96

Predicting outcome after traumatic brain injury: development and validation of a prognostic score based on admission characteristics. J Neurotrauma (2005) 1.96

Proton pump inhibitors reduce the risk of neoplastic progression in patients with Barrett's esophagus. Clin Gastroenterol Hepatol (2012) 1.96

Primitive neuroectodermal tumor: rare, highly aggressive differential diagnosis in urologic malignancies. Urology (2006) 1.94

Five-year follow-up of health-related quality of life after primary treatment of localized prostate cancer. Int J Cancer (2005) 1.93

Cure of Barrett's carcinoma by ifosfamide chemotherapy. Eur J Gastroenterol Hepatol (2002) 1.92

Empirical observations underestimate the proportion of human immunodeficiency virus infections attributable to sexually transmitted diseases in the Mwanza and Rakai sexually transmitted disease treatment trials: Simulation results. Sex Transm Dis (2006) 1.91

Clients of female sex workers in Nyanza province, Kenya: a core group in STD/HIV transmission. Sex Transm Dis (2002) 1.91

Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening. J Natl Cancer Inst (2009) 1.89

At what costs will screening with CT colonography be competitive? A cost-effectiveness approach. Int J Cancer (2009) 1.88

Differences in proximal serrated polyp detection among endoscopists are associated with variability in withdrawal time. Gastrointest Endosc (2013) 1.87

What proportion of episodes of gonorrhoea and chlamydia becomes symptomatic? Int J STD AIDS (2002) 1.87

Transcriptional profiling of Helicobacter pylori Fur- and iron-regulated gene expression. Microbiology (2005) 1.85

Age and sex distribution of the prevalence of Barrett's esophagus found in a primary referral endoscopy center. Am J Gastroenterol (2005) 1.85